Skip to content

Clinical observation and metabonomics study of acupuncture assisted PCI in the treatment of ACS

Clinical observation and metabonomics study of acupuncture assisted PCI in the treatment of ACS

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072265
Enrollment
Unknown
Registered
2023-06-08
Start date
2023-06-08
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

Acupuncture group:Routine emergency treatment for ACS with intraoperative acupuncture intervention during PCI
Control group:Routine emergency treatment for ACS

Sponsors

Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Emergency admission patients. 2)Age =18 years old, =80 years old, gender unlimited. 3)Patients who meet the diagnostic criteria for acute coronary syndrome and need elective PCI. 4)Understand and agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1)Patients in critical condition or with severely unstable vital signs. 2)Patients with serious liver or kidney damage, hematopoietic disorders, or other conditions (e.g. serum alanine aminotransferase > 3-fold normal ceiling or serum creatinine = 265?µmol/L). 3)Patients themselves cannot cooperate due to alcoholism, mental retardation, and other reasons. 4)Patients who cannot complete PCI. 5)Severe cardiac complications, such as cardiogenic shock, malignant arrhythmia, acute heart failure, etc. 6)Patients who have received previous acupuncture treatment and are unsuitable for acupuncture such as skin breakage or infection at the acupuncture site. 7)Patients who do not agree with hospitalization in our hospital and it is difficult to complete follow-up observation. 8)Patients who have undergone surgery in the last 4 weeks and are at risk of bleeding, or participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Incidence of slow flow in PCI;TCM symptom score;

Secondary

MeasureTime frame
Changes in myocardial enzyme profile;Electrocardiogram examination;Cardiac ultrasound examination;Chest pain score;Anxiety scores;Depression score;Biological markers of stress;Long-term endpoint events;

Countries

China

Contacts

Public ContactJia Zhou

Yueyang Hospital of Integrated Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

pdzhoujia@163.com+86 180 1730 6677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 12, 2026